Fiona Randall, PhD
Fiona Randall is head of external innovation at Eisai AiM Institute, where she manages preclinical drug discovery partnerships with external groups and Eisai researchers. A British neuroscientist and electrophysiologist, she has worldwide drug discovery experience — including in the United Kingdom, Japan, China, and the United States.
She trained in molecular biology in Edinburgh, going on to earn her PhD in neuroscience in Newcastle, United Kingdom, before doing a postdoctoral position in Okinawa, Japan. She moved to Shanghai to work in preclinical drug discovery for GlaxoSmithKline (GSK), joining Eisai Electrophysiology Group in the United Kingdom in 2012 before moving her lab to the United States in 2014. Since then, she has worked on an array of global drug discovery projects and built an alliance management function at Eisai to facilitate collaboration.
She is the United States leader on the Eisai Neurology Global Open Innovation Team and sits on the Eisai AiM Institute’s scientific and operational leadership team, which focuses on using human genetics to guide drug discovery for dementias.